At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ACHV Achieve Life Sciences, Inc.
Trading 03-28 13:20:38 EDT
2.80
-0.10
-3.45%
| High2.89 | Low2.76 | Vol37.01K |
| Open2.89 | D1 Closing2.90 | Amplitude4.46% |
| Mkt Cap97.12M | Tradable Cap82.37M | Total Shares34.69M |
| T/O104.18K | T/O Rate0.13% | Tradable Shares29.42M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
Insider Monkey · 03-20
Q4 2024 Achieve Life Sciences Inc Earnings Call
Thomson Reuters StreetEvents · 03-12
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
GuruFocus.com · 03-12
Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Dexcom (DXCM)
TIPRANKS · 03-11
Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
TIPRANKS · 03-11
Achieve Life Sciences Q4 EPS $(0.36) Misses $(0.32) Estimate
Benzinga · 03-11
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones · 03-11
Achieve Life Sciences Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 03-07
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025
GlobeNewswire · 03-06
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)
Insider Monkey · 02-18
Achieve Life Sciences (ACHV) Gets a Buy from Lake Street
TIPRANKS · 02-10
Achieve Life Sciences Inc - Reiterates Planned Nda Submission for Cytisinicline in Q2 2025
THOMSON REUTERS · 02-10
Achieve Life Sciences Inc - Dsmc Finds No Unexpected Adverse Events in Orca-Ol Trial
THOMSON REUTERS · 02-10
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the Orca-Ol Clinical Trial
THOMSON REUTERS · 02-10
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
GlobeNewswire · 02-10
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
Insider Monkey · 01-24
ACHV: Long-Term Exposure Requirement Complete
Zacks Small Cap Research · 01-21
Achieve Life Sciences appoints Slaoui, Phelan to board of directors
TIPRANKS · 01-10
Achieve Life Sciences Appoints DR. Kristen Slaoui and Nancy Phelan to Its Board of Directors
THOMSON REUTERS · 01-10
Press Release: Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors
Dow Jones · 01-10
Introduction
Company Name.
Achieve Life Sciences, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App